Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -38.00% | -45.57% | -49.02% | -50.65% | -643.55% |
Total Depreciation and Amortization | -8.62% | -3.61% | 18.25% | 14.49% | 346.27% |
Total Amortization of Deferred Charges | -16.27% | -11.67% | -- | -- | -12.05% |
Total Other Non-Cash Items | 57.90% | 66.57% | 17.12% | 19.76% | 426.68% |
Change in Net Operating Assets | -37.42% | -33.99% | 1.46% | -1.77% | -8.00% |
Cash from Operations | -54.88% | -52.41% | -14.29% | -17.02% | -36.04% |
Capital Expenditure | 68.03% | 66.27% | 23.92% | 26.34% | 50.57% |
Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -24.34% |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 30.09% | 26.25% | 31.95% | 34.12% | 37.48% |
Cash from Investing | 39.09% | 35.75% | 30.76% | 32.97% | 43.06% |
Total Debt Issued | -194.40% | -194.40% | -79.97% | -79.97% | -53.74% |
Total Debt Repaid | -58,822.01% | -58,822.01% | -12.38% | -12.38% | 99.80% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -100.00% |
Cash from Financing | 54.65% | 63.14% | -78.46% | -79.14% | -65.17% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -153.50% | -156.44% | -458.93% | -447.52% | 313.07% |